MedPath
NMPA Approval

Glecirasib Citrate Tablets

国药准字H20250020

May 20, 2025

Drug Information

枸橼酸戈来雷塞片

艾瑞凯

片剂

200mg(按C₃₁H₂₆ClF₄N₇O₂计)

化学药品

May 20, 2025

Company Information

Applicant Company

上海市浦东新区周浦镇凌霄花路268号

Manufacturing Company

天津开发区第七大街71号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

枸橼酸戈来雷塞片 - NMPA 批准文号 | MedPath